AI Pharma
Using data and intelligent tools to support R&D collaboration, production management, quality analysis, and efficiency.
VienKham AI Pharmaceuticals
Supporting R&D collaboration, production management, quality analysis, and operational efficiency through data-driven systems and intelligent tools.
Exploring New Possibilities in Pharmaceutical R&D with Artificial Intelligence
VienKham AI is an important future-oriented direction of Lao Wankang Pharmaceutical Co., Ltd. in the field of pharmaceutical technology. We aim to integrate artificial intelligence, computational biology, molecular simulation, pharmaceutical research, and formulation manufacturing capabilities to explore a more efficient, precise, and open approach to drug research and development.
Traditional drug development often involves long cycles, high costs, and high failure rates. The development of artificial intelligence provides new tools for target analysis, protein structure prediction, candidate molecule screening, drug interaction research, formulation optimization, and production quality management. VienKham AI hopes to apply AI technology to pharmaceutical R&D and manufacturing practice in an open, practical, and continuously evolving manner.
Our goal is not to replace scientific research with AI, but to use AI to improve research efficiency. We hope to help researchers identify promising directions more quickly, better understand molecular mechanisms, screen potential candidates more effectively, and ultimately create long-term value for human health through experimental verification and standardized production.
AI-Assisted Molecular Screening
VienKham AI Pharmaceuticals focuses on the application of AI in early-stage drug discovery. We plan to use open-source or publicly accessible AI tools such as Google DeepMind AlphaFold, along with other molecular modeling, virtual screening, and bioinformatics tools, to analyze protein structures, potential targets, candidate molecules, and molecular interactions.
Through AI-assisted computing, we can conduct preliminary screening from large public databases and candidate molecule libraries, helping research teams identify molecular structures with potential research value more efficiently. AI models can be used to analyze potential binding relationships between molecules and targets, predict certain physicochemical properties, and provide reference directions for subsequent experimental research.
Our key areas of focus include:
Protein structure prediction and target analysis
Candidate molecule structure screening
Analysis of potential molecule-target binding relationships
Preliminary evaluation of drug interactions
Research on natural products and plant-derived active ingredients
Exploration of formulation combinations and dosage form development
Preliminary screening through AI tools does not mean that direct drug conclusions can be obtained. All results must be supported by experimental verification, quality research, safety evaluation, and regulatory review. VienKham AI Pharmaceuticals upholds a rigorous scientific approach and regards AI as a research-supporting tool, not a shortcut that replaces validation.
Building Private AI Models and Pharmaceutical Knowledge Bases
In addition to using public AI tools, VienKham AI Pharmaceuticals is also planning to build private AI models and pharmaceutical knowledge bases tailored to its own business needs.
We hope to gradually establish an internal pharmaceutical data system around drug R&D, formulation processes, quality control, pharmacopoeial standards, production records, stability studies, raw and auxiliary material information, and market demand. Through long-term data accumulation and model training, AI can better understand our product direction, manufacturing capabilities, and quality management requirements.
The development directions of our private models include:
Organization of pharmaceutical literature and public research data
Analysis of drug ingredients and formulation information
Accumulation of formulation process parameters and experience
Structured management of quality control data
Analysis of production records and deviation data
Trend analysis of product stability
Knowledge base development for regulations, registration, and standard documents
Through these efforts, we hope that AI can be used not only to “discover molecules,” but also to “understand pharmaceutical manufacturing.” Truly valuable AI-driven pharmaceuticals are not limited to algorithmic capability in early-stage R&D. They also require a systematic understanding of production, quality, registration, supply chain, and clinical needs.
Connecting AI R&D with GMP Manufacturing
VienKham AI is supported by the GMP modern manufacturing facility of Lao Wankang Pharmaceutical Co., Ltd., giving it practical conditions to connect R&D concepts with formulation production.
The company has an approximately 6,000-square-meter GMP-standard production workshop, equipped with solid dosage production equipment, a quality control laboratory, and a standardized management system. In the future, VienKham AI Pharmaceuticals hopes to integrate AI screening, formulation research, process optimization, and quality management to build a complete capability from computational research to experimental verification, and from formulation design to standardized production.
Our advantage is not only “AI algorithms,” but also real pharmaceutical manufacturing scenarios. AI can help us identify directions, while the GMP system, production equipment, quality control, and professional team help us gradually transform those directions into verifiable, manageable, and manufacturable pharmaceutical R&D projects.
Focusing on Healthspan and Long-Term Value
VienKham AI Pharmaceuticals focuses not only on disease treatment, but also on the extension of human healthspan. As global population aging accelerates, research related to chronic disease management, metabolic health, nervous system health, immune regulation, inflammation control, and cellular aging is becoming an important direction in life sciences.
We hope to use AI technology to participate in broader healthspan research, including elderly health, chronic disease management, nutritional intervention, natural active ingredients, cellular protection mechanisms, and drug repurposing.
The true meaning of extending life is not only to increase lifespan, but to extend a healthy, meaningful, and dignified life. VienKham AI Pharmaceuticals is willing to cooperate openly with more research institutions, universities, hospitals, pharmaceutical companies, biotechnology companies, and data science teams around the world to contribute to the extension of human healthspan.
Open Collaboration and Joint Exploration
AI-driven pharmaceutical development is an interdisciplinary, cross-sector, and long-term endeavor. It requires the joint participation of artificial intelligence experts, biologists, pharmaceutical researchers, physicians, formulation engineers, quality management professionals, and industry partners.
VienKham AI Pharmaceuticals welcomes cooperation with more institutions to jointly carry out AI-assisted drug R&D, natural product research, candidate molecule screening, formulation development, dosage form transformation, quality research, and regional pharmaceutical projects.
We are open to collaboration in the following areas:
- AI drug discovery cooperation
- Molecular screening and target research cooperation
- Research on natural products and plant-derived active ingredients
- Formulation process development cooperation
- GMP manufacturing transformation cooperation
- Drug registration application and regional market cooperation
- Joint research with universities, research institutions, and enterprises
We believe that pharmaceutical companies of the future must have not only manufacturing capabilities, but also data capabilities, algorithmic capabilities, R&D capabilities, and open collaboration capabilities. Based in Laos, VienKham AI Pharmaceuticals hopes to connect regional resources with international technology and explore new possibilities for future pharmaceutical innovation.
Our Philosophy
AI makes drug R&D more efficient, and science makes results more reliable.
VienKham AI is committed to science as its foundation, data as its tool, quality as its bottom line, and collaboration as its path. We believe that truly valuable innovation is not a short-term concept, but the result of long-term accumulation, continuous validation, and stable implementation.
Our vision is:
To explore new directions in life sciences with AI.
To meet real-world health needs with pharmaceutical manufacturing capabilities.
To promote a longer and healthier future for humanity through open collaboration.
Consistency is Our Innovation.
Open exploration is our future.